Previous Article | Next Article 
Applied and Environmental Microbiology, September 2001, p. 3994-4000, Vol. 67, No. 9
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.9.3994-4000.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cosecretion of Chaperones and
Low-Molecular-Size Medium Additives Increases the Yield of
Recombinant Disulfide-Bridged Proteins
Jörg
Schäffner,
Jeannette
Winter,
Rainer
Rudolph, and
Elisabeth
Schwarz*
Institut für Biotechnologie,
Martin-Luther-Universität Halle-Wittenberg, 06120 Halle, Germany
Received 22 December 2000/Accepted 3 June 2001
 |
ABSTRACT |
Attempts were made to engineer the periplasm of Escherichia
coli to an expression compartment of heterologous proteins in their native conformation. As a first approach the low-molecular-size additive L-arginine and the redox compound glutathione
(GSH) were added to the culture medium. Addition of 0.4 M
L-arginine and 5 mM reduced GSH increased the yield of a
native tissue-type plasminogen activator variant (rPA), consisting of
the kringle-2 and the protease domain, and a single-chain antibody
fragment (scFv) up to 10- and 37-fold, respectively. A variety of other
medium additives also had positive effects on the yield of rPA. In a
second set of experiments, the effects of cosecreted ATP-independent
molecular chaperones on the yields of native therapeutic proteins were
investigated. At optimized conditions, cosecretion of E.
coli DnaJ or murine Hsp25 increased the yield of native rPA by
a factor of 170 and 125, respectively. Cosecretion of DnaJ also
dramatically increased the amount of a second model protein, native
proinsulin, in the periplasm. The results of this study are anticipated
to initiate a series of new approaches to increase the yields of
native, disulfide-bridged, recombinant proteins in the periplasm of
E. coli.
 |
INTRODUCTION |
Most therapeutically relevant
proteins contain disulfide bridges and cannot be produced in their
native conformation in the bacterial cytosol. In vitro refolding of
inclusion body material is often laborious and costly. An alternative
strategy to obtain these proteins in their native forms is to use their
secretion into the periplasmic space. Targeting of proteins to
the periplasm has both advantages and disadvantages. A major drawback
of the periplasm is that space is limited. Thus, yields of recombinant proteins generally never match those obtained upon cytosolic
expression. Also, translocation into the periplasmic space can
limit the final yields of recombinant proteins. However, in the case of
those proteins that bear multiple disulfide bonds of nonlinear
connectivities in their native conformations and that are resilient to
renaturation of inclusion body material, expression in the
periplasmic space may offer the method of choice. The periplasm
is a compartment where oxidation of thiols can occur due to the
activity of the disulfide oxidoreductase (Dsb) system (for a review,
see reference 28). The overall milieu of the periplasm is
strongly oxidizing, with the DsbA protein being the major oxidant.
However, Dsb components with disulfide isomerase functions, DsbC and
DsbG, have also been described (5, 40). Still, presumably
disulfide bond isomerization is insufficient in the periplasm, given
that recombinant proteins that carry multiple disulfide bonds in their
native conformations have a pronounced tendency to aggregate.
Considering this major drawback of the expression of
disulfide-containing proteins, the following strategies were devised to
optimize folding in the periplasm: (i) modification of the medium
composition by the addition of low-molecular-size compounds known to
stimulate folding in vitro, (ii) addition of a redox component to allow
reshuffling of wrongly formed disulfide bridges, and (iii) cosecretion
of ATP-independent chaperones.
As model proteins, a truncated version of tissue-type plasminogen
activator, consisting of the kringle-2 and the protease domain (BM
06.022, also known as rPA [23]), proinsulin, and a single-chain antibody fragment were chosen.
Our objective was to improve the yield of native rPA in the periplasm
of Escherichia coli. A beneficial effect was observed upon
the addition of low-molecular-size folding enhancers and reduced
glutathione (GSH) and also upon cosecretion of either DnaJ or Hsp25.
The general applicability of an optimized periplasmic expression compartment was confirmed with the two additional model proteins.
 |
MATERIALS AND METHODS |
Genetic and protein analytic techniques.
Cloning,
transformation of E. coli cells, and DNA preparations were
done by standard techniques (1). Oligonucleotides were purchased from Gibco BRL or MWG Biotech AG. Restriction enzymes were
obtained from Roche Molecular Biochemicals GmbH, AGS GmbH, or New
England Biolabs. Sequences of recloned DNA fragments were routinely
confirmed by dideoxy sequencing (LiCor DNA-Sequencer 4000; LiCor,
Lincoln, Nebr.). Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and Western blotting were carried out as described in
reference 8.
Strains, plasmids, proteins, and chemicals.
E.
coli strain BL21(DE3) was obtained from Novagen and used for gene
expression; E. coli N4830/pPL-dnaJ-23 as a DnaJ
overexpression strain was kindly provided by Thomas Langer (University
of Munich, Munich, Germany).
Plasmids of the pIN III ompA (16) series were kindly
provided by Masayori Inouye (University of Medicine and Dentistry of New Jersey), pMC111 M1 as a source for hsp25 DNA was
provided by Matthias Gaestel (University of Halle-Wittenberg), pA27fd7 (23) as a source for the rPA gene and rPA standard was
provided by Ulrich Kohnert (Roche Diagnostics), pUBS520
(6) was provided by Ulrich Brinkmann (Epidauros
Biotechnology, Bernried, Germany), and pHEN-scFv-ox
(12), containing a pelB signal sequence and a
lac promoter as a source for the scFv-ox gene, was provided by Ulrike Fiedler (Scil Proteins). Plasmid pCANTAB5-TSH, a secretion construct for a single-chain Fv fragment against thyroid-stimulating hormone (scFv-TSH) containing a gene 3 signal sequence and
the lac promoter, was provided by Alfred Engel (Roche
Diagnostics). scFv-TSH is directed against the thyroid stimulating hormone.
Antibody for insulin was a gift of Konrad Kürzinger (Roche
Diagnostics), and Hsp25 and DnaJ antibodies were kindly provided
by
Johannes Buchner (University of Munich, Munich, Germany) and
Maciej
Zylicz (University of Gdansk, Gdansk, Poland),
respectively.
Chemicals were of analytical grade and purchased from Sigma, Roth GmbH,
AppliChem GmbH, Biomol GmbH, Fluka, or ICN Pharmaceuticals.
Cultivation
medium substances were obtained from Becton Dickinson.
Other substances
and kits were bought from the suppliers as stated
below.
Construction of expression plasmids.
For cloning into
pET20b(+) (Novagen), the coding sequence of rPA was PCR amplified from
pA27fd7 (23) and inserted into pET20b(+). In this
construct the second amino acid of rPA (Ser) is replaced by Ala.
Proinsulin-encoding DNA was amplified by PCR from plasmid pRK-5-proinsulin (34) and ligated into pET20b(+). This
vector mediates secretion via the pelB signal sequence. By
QuikChange Mutagenesis (Stratagene), two surplus codons between signal
sequence and proinsulin were removed. For coexpression of chaperones
and model proteins, a two-plasmid expression system was chosen. After testing secretion of DnaJ and Hsp25, the genes were PCR cloned into pIN
III ompA3 (16) and the coding sequences of DnaJ and Hsp25
with the regulatory sequences were recloned into plasmid pUBS520
(6), which bears the p15A replication origin and kanamycin resistance. This vector also carries the dnaY gene encoding
the tRNA for the arginine codons AGA and AGG, which are rare in
E. coli and thus often limit expression of genes with these
codons (the gene for rPA contains seven of these rare arginine codons). The two-plasmid cosecretion system thus includes a vector for the
secretion of the disulfide-bridged model protein on the ColE1-based pET
vector and the chaperone on a p15A-based plasmid, which also carries
the dnaY gene. Both the gene for the model protein and the
chaperone were induced by the addition of
isopropyl-
-D-thiogalactopyranoside (IPTG). Via
PCR the coding and regulatory regions for scFv-ox were amplified from
pHEN-scFv-ox (12) and cloned into pUBS520.
Cultivation of E. coli BL21(DE3) and rPA
assay.
In order to test rPA activity, cells were grown in
Luria-Bertani medium at 24°C, induced with 1 mM IPTG at mid-log
phase, and cultivated for a further 21 h. Medium additives
(reduced GSH, 0 to 10 mM, and L-arginine, 0 to 0.4 M;
formamide, 0 to 1 M; methylformamide, 0 to 1 M; acetamide, 0 to 1 M; methylurea, 0 to 1 M; or ethylurea, 0 to 1 M) were
supplemented at the time of induction. After determination of the
optical density at 600 nm (OD600) (Pharmacia
Ultrospec 3000; Pharmacia Biotech), 2-ml samples were collected and
pelleted. For preparation of periplasmic extracts, the protocol
described in reference 18 was downscaled to milliliter
volumes. The soluble periplasmic fraction was assayed for rPA
activity. For control purposes, cultures of E. coli
BL21(DE3), transformed with pET20b(+) and pUBS520, were treated
identically. Determination of functional rPA on microplates was
performed according to a modified previously described protocol
(38) with purified rPA as a standard. The concentration of
rPA in the cellular extracts was determined by plotting the extinction
against the square of the reaction time. The slope of a linear
regression of this plot is directly proportional to the amount of rPA
in the assay. The native state of rPA in extracts was tested in
parallel assays after addition of 20 µl of 0.6-mg/ml fibrinogen
fragments. The slope of the plot after addition of fibrinogen
fragments divided by the slope in the absence of fibrinogen fragments
defines the stimulation factor (23).
To obtain quantitative values of the influence of cellular components
on the activity of rPA, purified rPA was diluted into
periplasmic extracts of
E. coli
BL21(DE3)/pET20b(+)/pUBS520. The
measured quenching of rPA activity
(1.5-fold) was used as a correction
factor for determinations of rPA
activities. All determinations
of rPA concentrations in the cellular
extracts were normalized
to 1 ml of cells at an
OD
600 of 1. Concentrations of
L-arginine
and glutathione in the cultivation
medium were determined with
diluted medium sample assays according to
the methods described
in references
13 and
17,
respectively.
Expression studies and determination of scFv-TSH.
E.
coli BL21(DE3) transformed with pCANTAB5-TSH and pUBS520 was
cultivated as described above in the presence of the indicated concentrations of reduced glutathione and
L-arginine. Expression of scFv-TSH was determined
via indirect enzyme-linked immunosorbent assay (ELISA) measurements
(8) and detected using the ImmunoPure TMB substrate system
(Pierce, Rockford, Ill.). The values of cell extracts without scFv-TSH
were used for correction of background signal. scFv-TSH purified with
the RPAS system (Amersham Pharmacia Biotech) was used as a standard.
Limited proteolysis of periplasmic DnaJ.
E.
coli XL1-blue cells, transformed with pIN III ompA3-dnaJ,
secreting DnaJ, and N4830/pPL-dnaJ-23 cells, overexpressing DnaJ in the
cytosol, were grown to mid-log phase and harvested 3 h after
induction by centrifugation. The equivalent of 2 ml of bacteria of an
OD600 of 1 were converted to spheroplasts according to the method described in reference 37. The spheroplasts were
resuspended in 30 µl of 50 mM Tris-HCl (pH 8.0)-100 mM NaCl with or
without 0.1% Triton X-100. For limited proteolysis, aliquots of these fractions were incubated with 25 µg of trypsin per ml. Proteolysis was stopped by the addition of 20 M excess soybean trypsin inhibitor. In a control experiment, 0.1 mg of purified DnaJ per ml was incubated with 6 µg of trypsin per ml and treated in the same way as the spheroplast samples. The samples were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and analyzed via Western blotting.
Cosecretion of proinsulin and DnaJ.
E. coli
BL21(DE3) cells harboring plasmids for cosecretion of proinsulin and
chaperones were grown in Luria-Bertani medium at 25°C. One millimolar
IPTG was added at an OD500 of 1, and cells were
harvested 6 h after induction. Soluble periplasmic protein was released by osmotic shock according to the method described in
reference 22. For analysis and quantification of native
proinsulin, an ELISA that specifically detects native (pro)insulin
(Enzymun Test Insulin; Roche Diagnostics) was carried out.
 |
RESULTS |
Yields of secreted rPA and scFv-TSH in the presence of medium
additives.
Tissue-type plasminogen activator (tPA) converts the
zymogen plasminogen to plasmin, a serine protease that degrades fibrin networks in thrombi (9). The tPA variant rPA contains nine disulfide bridges and aggregates upon cytosolic synthesis in inclusion bodies. In vitro refolding of rPA from inclusion body material is
routinely performed (A. Stern, U. Kohnert, R. Rudolph, S. Fischer, and U. Martin, June 1993, U.S. patent application 5,223,256). As
the native state of rPA can easily be assessed, it was chosen as a
model protein for expression in the native conformation in the
periplasm. For secretion of rPA, plasmid vector pET20b(+) (Novagen), containing the signal sequence of PelB (pectate lyase from
Erwinia carotovora), was used. To determine the amount
of functional rPA, protease activity was assayed according to the method described in reference 38 with minor
modifications (see Materials and Methods).
The characteristic feature of rPA

the stimulation of the protease
activity by fibrinogen fragments (
23)

was used as an
indication
of the native state of the two-domain protein. rPA with
correctly
folded kringle and protease domains possessed proteolytic
activity
which could be stimulated by a factor of ca. 25 to 35 by
fibrinogen
fragments (
23; Stern et al., October 1992, U.S.
patent application
5,223,256). We first verified that stimulation by
fibrinogen fragments
was not affected when purified rPA was incubated
with periplasmic
extracts (data not shown), a prerequisite for
testing native expression
of the protease in the
periplasm.
Periplasmic extracts were prepared from cells secreting rPA and control
cells. Extracts from the control culture showed only
low background
protease activity which was not affected by fibrinogen
fragments (data
not shown). In the strain secreting rPA, 0.023
ng of active rPA per ml
was determined in periplasmic extracts.
As the activity could
be stimulated 35-fold by fibrinogen fragments,
rPA was assumed to be
responsible for proteolytic
activity.
The nine disulfide bridges of rPA are essential for the native
conformation and consequently the activity of the protease.
To
facilitate reshuffling of incorrect disulfide bonds, GSH was
added to the culture medium (
39; R. Glockshuber, M. Wunderlich,
A. Skerra, and R. Rudolph European
patent application EPO 510
658) (Fig.
1A). The addition of 5 or 10 mM GSH
resulted in a slight
increase of protease activity. These
results indicate that disulfide
shuffling is enhanced when
reducing reagents are added to the
culture medium.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 1.
Increases of the yields of secreted rPA and scFv-TSH
upon addition of L-arginine to the cultivation medium. (A)
Yields of native rPA in the periplasm of E. coli
BL21(DE3)/pET20b(+)-rPA after cultivation (24°C) in the presence of
the indicated concentrations of reduced GSH and L-arginine.
Active rPA was determined as described previously (38).
(B) Yields of native single-chain Fv (scFv-TSH) in the periplasm of
E. coli BL21(DE3)/pCANTAB5-TSH after cultivation
(24°C) in the presence of the indicated concentrations of
L-arginine and GSH. Native scFv-TSH was determined using
ELISA measurements. Mean values of at least three shake flask cultures
and standard deviations are indicated.
|
|
L-Arginine is known to effectively improve the yield of
native protein during in vitro refolding from inclusion body material
(
10,
25,
30). Thus, the in vivo effect of
L-arginine on
the yield of secreted native rPA was
investigated. In the absence
of GSH and at a concentration of 0.4 M
L-arginine, the yield of
active plasminogen activator
increased about 10-fold (Fig.
1A).
Interestingly, in the presence of
L-arginine, the addition of
GSH had no beneficial effect on
the yield of
rPA.
The yield of a second secreted model protein, a scFv-TSH
(
21), was also increased by the presence of
L-arginine and reduced
GSH. Addition of 0.4 M
L-arginine led to the highest yield of
native scFv-TSH
(Fig.
1B), a 37-fold increase over the control
expression. Though
absolute yields with 25 ng/ml appear moderate,
the results show that
L-arginine is a compound that can be used
to optimize
folding of secreted proteins. A portion of the secreted
scFv-TSH
was detected in the medium supernatant, and the addition
of 0.4 M
L-arginine moderately increased the yield of scFv in
the
supernatant (data not shown). Concentrations of
L-arginine
higher than 0.4 M inhibited bacterial growth almost completely
and
led to reduced yields of scFv-TSH and rPA (data not shown).
Taken
together, these results demonstrate that in vivo structure
formation of
the two tested model proteins was significantly stimulated
by the
addition to the growth medium of
L-arginine and, to a
lesser
extent, reduced
GSH.
To determine whether GSH or
L-arginine would be stably
maintained during cell growth, the concentrations of GSH and
L-arginine
were determined by enzymatic analysis after
extended culturing.
Concentrations of
L-arginine and total
GSH in the culture medium
remained constant during the entire
culture process (20 h; Fig.
2A and B).
However, the ratio of reduced GSH to oxidized GSH changed
dramatically
over 20 h at 24°C. During the first 5 h of cultivation
almost all GSH was maintained in the reduced state. This ratio
shifted
to ca. 20% reduced GSH and 80% oxidized GSH after 20 h
of
cultivation, due to air oxidation of the thiol groups (Fig.
2B). These
data confirm that a disulfide-shuffling system consisting
of reduced
and oxidized GSH can be maintained for 20 h during
fermentation of
the
E. coli cells under aerobic conditions.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Determination of the concentrations of
L-arginine and GSH in the medium of E. coli
BL21(DE3) after prolonged cultivation according to the methods
described in references 13 and 17. (A)
Determined L-arginine concentrations in the cultivation
medium at the indicated time points after induction. At the time of
induction L-arginine was added to the culture medium to
final concentrations of either 0.2 M (filled circles) or 0.4 M (open
circles). (B) Concentrations of GSH (closed triangles) and total GSH
(GSH+GSSG; open triangles) in the cultivation medium after addition of
5 mM GSH.
|
|
Construction of a two-plasmid system for cosecretion of DnaJ
and Hsp25.
In order to further increase the yield of
secreted proteins, cosecretion of ATP-independent chaperones was
tested. In a first experiment, the cosecretion of DnaJ was
analyzed. This protein belongs to the Hsp70 (DnaK) system of E. coli and is known to suppress aggregation of nonnative proteins
also in the absence of Hsp70 (7, 24, 31).
DnaJ, secreted by fusion to the OmpA signal peptide, was detected in
the membrane fraction of periplasmic proteins (data not
shown).
This was expected, as DnaJ is known to associate with
membranes
(
2). To confirm the native conformation of secreted
DnaJ,
limited proteolysis experiments were performed. Spheroplasts
of
E. coli XL1-blue/pIN III-dnaJ, secreting the chaperone, and
N4830/pPL-dnaJ-23 (
41), a control strain which
overexpresses
DnaJ in the cytoplasm, were prepared (
37).
Both spheroplast
preparations were subjected to limited proteolysis
with trypsin
(Fig.
3). In intact
spheroplasts, intracellular DnaJ of strain
N4830 was completely
protected from trypsin digestion, whereas
secreted DnaJ, expressed in
strain BL21(DE3)/pIN III-dnaJ, was
susceptible to proteolysis (Fig.
3).
The defined products of partial
trypsinolysis were similar in size to
those obtained by digestion
of purified native DnaJ, a fact that
suggests the native conformation
of secreted DnaJ.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 3.
Limited proteolysis for determination of native DnaJ.
Spheroplasts were incubated with 25 µg of trypsin per ml and purified
DnaJ was incubated with 6 µg of trypsin per ml for the indicated
times. Proteolysis products of DnaJ and its fragments were detected
with a rabbit anti-DnaJ antibody and subsequently with a donkey
anti-rabbit immunoglobulin G horseradish peroxidase conjugate (Amersham
Pharmacia Biotech).
|
|
The effect of a second cosecreted chaperone, murine Hsp25 (
14,
19), on the yield of recombinant proteins in the periplasm
was investigated. Like DnaJ, Hsp25 has been demonstrated to prevent
aggregation of nonnative proteins (
11). Translocation of
Hsp25
into the periplasm was also mediated by the OmpA signal
peptide.
Expression and secretion of Hsp25 were confirmed by Western
blotting
experiments (data not
shown).
Yields of native rPA and proinsulin in the periplasm of
E. coli upon cosecretion of DnaJ and
Hsp25.
Cosecretion of DnaJ yielded a fivefold increase of
functional rPA in periplasmic extracts compared to what was
observed with the clone without cosecretion. Upon addition of
fibrinogen fragments, protease activity was stimulated 35-fold,
indicating the native conformation of the secreted rPA. Under optimal
expression conditions (0.4 M L-arginine and 5 mM GSH), the
yield increased 170-fold (Table 1).
Similarly, cosecretion of Hsp25 increased the yield of native rPA in
the periplasm ca. twofold. Under optimal expression conditions,
i.e., 5 mM GSH and 0.4 M
L-arginine (optimization data not
shown),
cosecretion of Hsp25 resulted in a 120-fold increase of active
plasminogen activator (Table
1 and Fig.
4) compared to what was
observed for the
strain which did not secrete Hsp25 cultivated
in the absence of medium
additives.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of cosecreted chaperones and scFv-ox (control)
on the yields of native rPA at different concentrations of
L-arginine. Cells were grown in the presence of 5 mM GSH.
Active rPA was determined as described previously (38).
Mean values of at least three shake flask culture experiments and
standard deviations are indicated.
|
|
The fact that both DnaJ and Hsp25 enhanced the yield of native rPA
could be due either to the chaperone activities of these
proteins or to
indirect effects caused by the secretion of a second
heterologous
protein to the periplasmic space. To test the latter
possibility, the effect of cosecretion of scFv-ox (
12), a
protein
which lacks chaperone function, on the yield of native rPA was
investigated. Under optimal conditions, cosecretion of scFv-ox
yielded
a fourfold increase of native rPA compared to the situation
when rPA
was expressed alone. However, the very low stimulation
factor of 10 (Table
1) indicated incomplete folding of rPA. Thus,
the huge
increase of native rPA upon cosecretion of chaperones
is very likely
caused by the chaperoning activities of these proteins.
Western
blot experiments confirmed that the levels of DnaJ and
Hsp25 remained
constant at the concentrations of
L-arginine and
GSH tested
here. In contrast, increases in scFv-ox levels were
observed with
increasing concentrations of
L-arginine (data not
shown).
As a second model protein for testing the effects of cosecreted
chaperones, proinsulin was secreted to the periplasm. The
amounts
of native proinsulin in periplasmic fractions were assayed
by
ELISA using an antibody recognizing selectively native insulin.
In the
absence of cosecreted chaperones, 2 ng of native proinsulin
per ml was
detected (Fig.
5). When Hsp25 was
cosecreted with proinsulin,
no native proinsulin was detectable in the
periplasm. In contrast,
coexpression of DnaJ resulted in 74 ng of
native proinsulin per
ml, corresponding to a 37-fold increase of the
yield. Upon cosecretion
of the negative control, scFv-ox, only 0.3 ng
of native proinsulin
per ml was detected. Surprisingly, in this case,
the presence
of 0.4 M
L-arginine decreased the amount of
native proinsulin
to 50% of that of cultivations in the absence
of
L-arginine (data
not shown). With the third model
protein, scFv-TSH, cosecretion
of DnaJ or Hsp25 did not increase the
yield of native scFv-TSH
in the periplasm.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 5.
Yields of proinsulin after cosecretion of DnaJ, Hsp25,
and scFv-ox (control). Proinsulin was determined by ELISA (see
Materials and Methods). Values represent mean values of at least three
shake flask culture experiments. Standard deviations are indicated.
|
|
Influence of low-molecular-size additives on the yield of
secreted rPA.
In in vitro refolding experiments, several
low-molecular-size additives, especially derivatives of formamide or
urea, proved useful for increasing the yield of native rPA
(29). We therefore examined the effects of formamide,
methylformamide, acetamide, methylurea, and ethylurea on
the yield of native rPA. Bacteria were able to grow in media which
contained concentrations of up to 1 M formamide or acetamide but only
up to 0.6 M methylformamide, methylurea, or ethylurea. The
yield of native rPA was tested with the strain E. coli
BL21(DE3)/pUBS520-dnaJ/pET20b(+)-rPA cosecreting DnaJ upon
cultivation in the presence of these additives and 5 mM GSH. Although
L-arginine, which was used for comparison, proved to be the most effective additive, acetamide or ethylurea also had
significant beneficial effects on the yield of rPA (Fig.
6).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 6.
Yields of native rPA in E. coli secreting
DnaJ in the presence of 5 mM GSH and low-molecular-size additives at
the indicated concentrations. Active rPA was determined as
described previously (38).
|
|
 |
DISCUSSION |
Native expression of disulfide-bridged proteins in
prokaryotic host cells remains a scientific challenge
(32). Though approaches have been taken to change
the cytosolic milieu of E. coli to more oxidizing
conditions to allow intracellular formation of disulfide bonds
(4, 35), expression of disulfide-bridged proteins in the
periplasmic space is an alternative strategy that has not been fully exploited. A major disadvantage of the periplasm as a
folding compartment for proteins with multiple disulfide bonds is the
strong oxidant DsbA. DsbA has been shown to introduce disulfide bonds
into translocating polypeptides as soon as two cysteines have emerged
into the periplasm (20, 33). Although disulfide isomerases exist in the periplasm, their function is obviously insufficient to correct wrongly paired cysteines of proteins containing multiple disulfide bonds of nonlinear connectivities (3,
26). The consequence is usually inclusion body formation of
these misfolded proteins in the periplasm (15).
Our approach to overcome these problems was to suppress inclusion body
formation in the periplasm by adding disulfide-reshuffling reagents
and substances known to stabilize folding intermediates to the
cultivation medium. Also, the effects of cosecreted ATP-independent molecular chaperones DnaJ and Hsp25, which have been shown to suppress
aggregation of nonnative proteins in vitro (11, 31), were analyzed.
We were able to increase the yield of native rPA in the periplasm
of E. coli up to 170-fold upon cosecretion of DnaJ and
125-fold upon cosecretion of Hsp25. This huge increase is, to our
understanding, mainly due to a synergistic effect of the respective
cosecreted chaperone and medium additives on the folding of rPA, as
cosecretion of DnaJ or Hsp25 in the absence of medium additives gave
rise to ca. fivefold or twofold increases, respectively, of rPA (Table 1). Improvement of the periplasm as an expression compartment for
disulfide-bridged proteins has been reported earlier (27). For example, overexpression of DsbC considerably increased the yield of
full-length tPA (27). Unfortunately, the yields of functional proteins published in reference 27 and those of
our studies cannot be compared, as a variant of tPA has been used in
the latter; furthermore, the data of the former study result from high
cell density fermentations, whereas here shake flask cultures were used.
The fact that 5 mM GSH was optimal for the folding of rPA under almost
all tested conditions confirms previous results that demonstrate that
addition of GSH improved folding of an
-amylase-trypsin inhibitor in
the periplasm (39).
With proinsulin, a 37-fold increase in the yield of native protein was
obtained by cosecretion of DnaJ. Proinsulin secreted to the
periplasm has been reported to be degraded by E. coli proteases (36). The presence of DnaJ may prevent
the action of proteases and promote native structure formation.
Cosecretion of Hsp25 or addition of L-arginine,
however, did not improve the yield of native protein.
The increases of native rPA and proinsulin upon cosecretion of DnaJ and
Hsp25 are likely to be due to the specific chaperoning activities of
these proteins. Our interpretation that we are dealing with specific
chaperone functions in cases where we observe increased amounts of
folded proteins upon cosecretion of the chaperones is supported by the
following observations. (i) If cosecretion of a heterologous protein
should unspecifically enhance folding of rPA and proinsulin, cosecreted
scFv-ox should have increased the yield. Furthermore, cosecretion of
scFv-ox did not result in efficient stimulation of rPA activity by
fibrinogen fragments by factors known for the completely folded
protease. (ii) The chaperone requirement of a given protein is known to
be relatively specific. In accordance with this notion, cosecretion of
Hsp25 proved not to be effective in the case of proinsulin and neither DnaJ nor Hsp25 increased the yield of scFv-TSH. Thus, we propose that
the beneficial effects of the secreted chaperones reflect the folding
activities of DnaJ and Hsp25.
Besides L-arginine, a series of low-molecular-size reagents
added to the cultivation medium increased the yield of active rPA. We
limited our investigations to additives for which effects on the in
vitro refolding of full-length tissue-type plasminogen activator had
been demonstrated (29). Although L-arginine
was the most effective compound in the case of rPA, other
low-molecular-size additives may prove most efficient with different
proteins. The effects of the tested additives on the yield of rPA are
comparable to those obtained by in vitro refolding experiments
(29). Therefore, we consider the effects to be due to the
folding-enhancing activities of the compounds and not to their
secondary osmolytic effects on cells.
Our results demonstrate that cosecretion of ATP-independent chaperones
and the use of low-molecular-size medium additives to the culture
medium can dramatically increase the yield of native eukaryotic
proteins with complex disulfide patterns in the periplasm of
E. coli. The mechanism by which the chaperones act in the
periplasm remains unclear and needs further investigation. Still,
this study may open new avenues for the production of disulfide-bridged
proteins in their native conformation in prokaryotic organisms.
 |
ACKNOWLEDGMENTS |
This work was supported by a grant of the Bundesministerium
für Bildung, Wissenschaft, Forschung und Technologie (BMBF) of Germany. J.W. was supported by a grant of the
Graduiertenförderung des Landes Sachsen-Anhalt and a project of
the European Commission (project no. EU BIO4-CT96-0436). The support of
the Fonds der Chemischen Industrie is gratefully acknowledged.
We thank Jason Smith for critically reading the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address:
Martin-Luther-Universität Halle-Wittenberg, Institut für
Biotechnologie, Kurt-Mothes-Str. 3, 06120 Halle, Germany. Phone: 49 345 5524856. Fax: 49 345 5527013. E-mail:
elisabeth.schwarz{at}biochemtech.uni-halle.de.
Present address: Scil Proteins GmbH, 06120 Halle, Germany.
 |
REFERENCES |
| 1.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidmann,
J. A. Smith, and K. Struhl (ed.).
1987.
-1997.
In
Current protocols in molecular biology. John Wiley & Sons, Cambridge, United Kingdom.
|
| 2.
|
Bardwell, J. C. A.,
K. Tilly,
E. Craig,
J. King,
M. Zylicz, and C. Georgopoulos.
1986.
The nucleotide sequence of the Escherichia coli K12 dnaj+ gene.
J. Biol. Chem.
261:1782-1785[Abstract/Free Full Text].
|
| 3.
|
Bardwell, J. C. A.
1994.
Building bridges: disulfide bond formation in the cell.
Mol. Microbiol.
14:199-205[CrossRef][Medline].
|
| 4.
|
Bessette, P. H.,
F. Aslund,
J. Beckwith, and G. Georgiou.
1999.
Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm.
Proc. Natl. Acad. Sci. USA
96:13703-13708[Abstract/Free Full Text].
|
| 5.
|
Bessette, P. H.,
J. J. Cotto,
H. F. Gilbert, and G. Georgiou.
1999.
In vivo and in vitro function of the Escherichia coli periplasmic cysteine oxidoreductase DsbG.
J. Biol. Chem.
274:7784-7792[Abstract/Free Full Text].
|
| 6.
|
Brinkmann, U.,
R. E. Mattes, and P. Buckel.
1989.
High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product.
Gene
85:109-114[CrossRef][Medline].
|
| 7.
|
Bukau, B., and A. Horwich.
1998.
The Hsp70 and Hsp60 chaperone machines.
Cell
92:351-366[CrossRef][Medline].
|
| 8.
|
Coligan, J. E.,
B. M. Dunn,
H. L. Ploegh,
D. W. Speicher, and P. T. Wingfield (ed.).
1995.
-1997.
In
Current protocols in protein science. John Wiley & Sons, Washington, D.C.
|
| 9.
|
Collen, D., and H. R. Lijnen.
1995.
Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
Thromb. Haemostasis
74:167-171[Medline].
|
| 10.
|
De Bernandez Clark, E.,
E. Schwarz, and R. Rudolph.
1999.
Inhibition of aggregation side reactions during in vitro protein folding.
Methods Enzymol.
309:217-236[Medline].
|
| 11.
|
Ehrnsperger, M.,
S. Gräber,
M. Gaestel, and J. Buchner.
1997.
Binding of non-native protein to Hsp25 during heat shock creates a reservoir of folding intermediates for reactivation.
EMBO J.
16:221-229[CrossRef][Medline].
|
| 12.
|
Fiedler, U., and U. Conrad.
1995.
High-level production and long-term storage of engineered antibodies in transgenic tobacco seeds.
Bio/Technology
13:1090-1093[CrossRef][Medline].
|
| 13.
|
Gäde, G.
1989.
L-Arginine and L-arginine phosphate, p. 425-432.
In
H. U. Bergmeyer (ed.), Methods of enzymatic analysis, 3rd ed., vol. VIII. (Metabolites 3). VCH, Weinheim, Germany.
|
| 14.
|
Gaestel, M.,
B. Gross,
R. Benndorf,
M. Strau ,
W.-H. Schunk,
R. Kraft,
A. Otto,
H. Böhm,
J. Stahl,
H. Drabsch, and H. Bielka.
1989.
Molecular cloning, sequencing and expression in Escherichia coli of the 25-kDa growth-related protein of Ehrlich ascites tumor and its homology to mammalian stress proteins.
Eur. J. Biochem.
179:209-213[Medline].
|
| 15.
|
Georgiou, G.,
J. N. Telford,
M. L. Shuler, and D. B. Wilson.
1986.
Localization of inclusion bodies in Escherichia coli overproducing -lactamase or alkaline phosphatase.
Appl. Environ. Microbiol.
52:1157-1161[Abstract/Free Full Text].
|
| 16.
|
Ghayreb, J.,
H. Kimura,
M. Takahara,
H. Hsiung,
Y. Masui, and M. Inouye.
1984.
Secretion cloning vectors in Escherichia coli.
EMBO J.
3:2437-2442[Medline].
|
| 17.
|
Griffith, O. W.
1989.
Glutathione and glutathione disulphide, p. 521-529.
In
H. U. Bergmeyer (ed.), Methods of enzymatic analysis, 3rd ed., vol. VIII. (Metabolites 3). VCH, Weinheim, Germany.
|
| 18.
|
Jacobi, A.,
M. Huber-Wunderlich,
J. Hennecke, and R. Glockshuber.
1997.
Elimination of all charged residues in the vicinity of the active-site helix of the disulfide oxidoreductase DsbA.
J. Biol. Chem.
272:21692-21699[Abstract/Free Full Text].
|
| 19.
|
Jakob, U.,
M. Gaestel,
K. Engel, and J. Buchner.
1993.
Small heat shock proteins are molecular chaperones.
J. Biol. Chem.
268:1517-1520[Abstract/Free Full Text].
|
| 20.
|
Joly, J. C., and J. R. Swartz.
1997.
In vitro and in vivo redox states of the Escherichia coli periplasmic oxidoreductases DsbA and DsbC.
Biochemistry
36:10067-10072[CrossRef][Medline].
|
| 21.
| Kaluza, B., and H. Lenz. March 1997. Diagnostic test using chimeric antibodies. U.S. patent 5,614,367.
|
| 22.
|
Kang, Y., and J.-W. Yoon.
1994.
Effect of modification of connecting peptide of proinsulin on its export.
J. Biotechnol.
36:45-54[CrossRef][Medline].
|
| 23.
|
Kohnert, U.,
R. Rudolph,
J. H. Verheijen,
E. J. D. Weening-Verhoeff,
A. Stern,
U. Opitz,
U. Martin,
H. Lill,
H. Prinz,
M. Lechner,
G.-B. Kresse,
P. Buckel, and S. Fischer.
1992.
Biochemical properties of the kringle-2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022.
Protein Eng.
5:93-100[Abstract/Free Full Text].
|
| 24.
|
Langer, T.,
C. Lu,
H. Echols,
J. Flanagan,
M. K. Hayer, and F. U. Hartl.
1992.
Successive action of DnaK, DnaJ and GroEL along the pathway of chaperone-mediated protein folding.
Nature
356:683-689[CrossRef][Medline].
|
| 25.
|
Lilie, H.,
E. Schwarz, and R. Rudolph.
1998.
Advances in refolding of proteins produced in E. coli.
Curr. Opin. Biotechnol.
9:497-501[CrossRef][Medline].
|
| 26.
|
Missiakas, D., and S. Raina.
1997.
Protein folding in the bacterial periplasm.
J. Bacteriol.
179:2465-2471[Free Full Text].
|
| 27.
|
Qiu, J.,
J. R. Swartz, and G. Georgiou.
1998.
Expression of active human tissue-type plasminogen activator in Escherichia coli.
Appl. Environ. Microbiol.
64:4891-4896[Abstract/Free Full Text].
|
| 28.
|
Rietsch, A., and J. Beckwith.
1998.
The genetics of disulfide bond metabolism.
Annu. Rev. Genet.
32:163-184[CrossRef][Medline].
|
| 29.
| Rudolph, R., S. Fischer, and R. Mattes.
January 1997. Process for the activating of gene-technologically
produced, heterologous, disulphide bridge-containing eukaryotic
proteins after expression in prokaryotes. U.S. patent 5,593,865.
|
| 30.
|
Rudolph, R., and H. Lilie.
1996.
In vitro folding of inclusion body proteins.
FASEB J.
10:49-56[Abstract].
|
| 31.
|
Schröder, H.,
T. Langer,
F. U. Hartl, and B. Bukau.
1993.
DnaK, DnaJ and GrpE form a cellular chaperone machinery capable of repairing heat-induced protein damage.
EMBO J.
12:4137-4144[Medline].
|
| 32.
|
Schwarz, E.,
H. Lilie, and R. Rudolph.
1996.
The effect of molecular chaperones on in vivo and in vitro folding processes.
Biol. Chem.
377:411-416[Medline].
|
| 33.
|
Sone, M.,
Y. Akiyama, and K. Ito.
1997.
Differential in vivo roles played by DsbA and DsbC in the formation of protein disulfide bonds.
J. Biol. Chem.
272:10349-10352[Abstract/Free Full Text].
|
| 34.
|
Stahl, S. J., and L. Christiansen.
1988.
Selection for signal sequence mutations that enhance production of secreted human proinsulin by Escherichia coli.
Gene
71:147-156[CrossRef][Medline].
|
| 35.
|
Stewart, E. J.,
F. Aslund, and J. Beckwith.
1998.
Disulfide bond formation in the Escherichia coli cytoplasm: an in vivo role reversal for the thioredoxins.
EMBO J.
17:5543-5550[CrossRef][Medline].
|
| 36.
|
Talmadge, K., and W. Gilbert.
1982.
Cellular location affects protein stability in Escherichia coli.
Proc. Natl. Acad. Sci. USA
79:1830-1833[Abstract/Free Full Text].
|
| 37.
|
Thorstenson, Y.,
Y. Zhang,
P. S. Olson, and D. Mascarenhas.
1997.
Leaderless polypeptides efficiently extracted from whole cells by osmotic shock.
J. Bacteriol.
179:5333-5339[Abstract/Free Full Text].
|
| 38.
|
Verheijen, J. H.,
E. Mullaart,
G. T. G. Chang,
C. Kluft, and G. A. Wijngaards.
1982.
A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma.
Thromb. Haemostasis
48:266-269[Medline].
|
| 39.
|
Wunderlich, M., and R. Glockshuber.
1993.
In vivo control of redox potential during protein folding catalyzed by bacterial protein disulfide-isomerase (DsbA).
J. Biol. Chem.
268:24547-24550[Abstract/Free Full Text].
|
| 40.
|
Zapun, A.,
D. Missiakas,
S. Raina, and T. E. Creighton.
1995.
Structural and functional characterization of DsbC, a protein involved in disulfide bond formation in Escherichia coli.
Biochemistry
34:5075-5089[CrossRef][Medline].
|
| 41.
|
Zylicz, M.,
T. Yamamoto,
N. McKittrick,
S. Sell, and C. Georgopoulos.
1985.
Purification and properties of the dnaJ replication protein of Escherichia coli.
J. Biol. Chem.
260:7591-7598[Abstract/Free Full Text].
|
Applied and Environmental Microbiology, September 2001, p. 3994-4000, Vol. 67, No. 9
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.9.3994-4000.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kim, J.-Y., Fogarty, E. A., Lu, F. J., Zhu, H., Wheelock, G. D., Henderson, L. A., DeLisa, M. P.
(2005). Twin-Arginine Translocation of Active Human Tissue Plasminogen Activator in Escherichia coli. Appl. Environ. Microbiol.
71: 8451-8459
[Abstract]
[Full Text]
-
Mukherjee, K. J., Rowe, D. C. D., Watkins, N. A., Summers, D. K.
(2004). Studies of Single-Chain Antibody Expression in Quiescent Escherichia coli. Appl. Environ. Microbiol.
70: 3005-3012
[Abstract]
[Full Text]
-
Dieye, Y., Hoekman, A. J. W., Clier, F., Juillard, V., Boot, H. J., Piard, J.-C.
(2003). Ability of Lactococcus lactis To Export Viral Capsid Antigens: a Crucial Step for Development of Live Vaccines. Appl. Environ. Microbiol.
69: 7281-7288
[Abstract]
[Full Text]